Search Results - "Bally, Cecile"

Resistance to Therapy in Acute Promyelocytic Leukemia by Lehmann-Che, Jacqueline, Bally, Cecile, de Thé, Hugues

“…Resistance to treatment in patients with acute promyelocytic leukemia is rare. The authors describe the development of resistance to arsenic through a mutation…”
Get full text

Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia by Maslah, Nabih, Salomao, Norman, Drevon, Louis, Verger, Emmanuelle, Partouche, Nicolas, Ly, Pierre, Aubin, Philippe, Naoui, Nadia, Schlageter, Marie-Helene, Bally, Cecile, Miekoutima, Elsa, Rahmé, Ramy, Lehmann-Che, Jacqueline, Ades, Lionel, Fenaux, Pierre, Cassinat, Bruno, Giraudier, Stephane

“…Myelodysplastic syndromes and acute myeloid leukemia with TP53 mutations are characterized by frequent relapses, poor or short responses, and poor survival…”
Get full text

Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL Group by BALLY, Cecile, FADLALLAH, Jehane, LEBLANC, Thierry, IDRES, Nadia, CASSINAT, Bruno, VEY, Norbert, CHOMIENNE, Christine, DOMBRET, Herve, SANZ, Miguel, FENAUX, Pierre, ADES, Lionel, LEVERGER, Guy, BERTRAND, Yves, ROBERT, Alain, BARUCHEL, Andre, GUERCI, Agnes, RECHER, Christian, RAFFOUX, Emmanuel, THOMAS, Xavier

“…Acute promyelocytic leukemia (APL) is rare in children. All-trans-retinoic acid (ATRA) combined with chemotherapy, the reference treatment of APL, is generally…”
Get full text

Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM) by Bally, Cecile, Thépot, Sylvain, Quesnel, Bruno, Vey, Norbert, Dreyfus, Francois, Fadlallah, Jehane, Turlure, Pascal, de Botton, Stephane, Dartigeas, Caroline, de Renzis, Benoit, Itzykson, Raphael, Fenaux, Pierre, Adès, Lionel

“…Abstract The effect of azacitidine (AZA) in therapy related MDS and AML (t-MDS/AML) is not well established. 54 patients (42 t-MDS and 12 t-AML), 71% of whom…”
Get full text

Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia by Lehmann-Che, Jacqueline, Bally, Cécile, Letouzé, Eric, Berthier, Caroline, Yuan, Hao, Jollivet, Florence, Ades, Lionel, Cassinat, Bruno, Hirsch, Pierre, Pigneux, Arnaud, Mozziconacci, Marie-Joelle, Kogan, Scott, Fenaux, Pierre, de Thé, Hugues

“…Retinoic acid (RA) and arsenic target the t(15;17)(q24;q21) PML/RARA driver of acute promyelocytic leukemia (APL), their combination now curing over 95%…”
Get full text

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure by Sébert, Marie, Renneville, Aline, Bally, Cécile, Peterlin, Pierre, Beyne-Rauzy, Odile, Legros, Laurence, Gourin, Marie-Pierre, Sanhes, Laurence, Wattel, Eric, Gyan, Emmanuel, Park, Sophie, Stamatoullas, Aspasia, Banos, Anne, Laribi, Kamel, Jueliger, Simone, Bevan, Luke, Chermat, Fatiha, Sapena, Rosa, Nibourel, Olivier, Chaffaut, Cendrine, Chevret, Sylvie, Preudhomme, Claude, Adès, Lionel, Fenaux, Pierre

“…High-risk myelodysplastic syndrome/acute myeloid leukemia patients have a very poor survival after azacitidine failure. Guadecitabine (SGI-110) is a novel…”
Get full text

Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient by Harroche, Annie, Sefiane, Thibaud, Desvages, Maximilien, Borgel, Delphine, Lasne, Dominique, Casari, Caterina, Peyron, Ivan, Frenzel, Laurent, Chhun, Stéphanie, Lenting, Peter J, Bally, Cécile

“…Authorship Contributions: AH, CB were in charge of the patients and provided the clinical samples. MD, DB and DL performed the coagulation tests. TS, CC, IP…”
Get full text

Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network by Meunier, Sandrine, Harroche, Annie, Rauch, Antoine, Bally, Cécile, Huguenin, Yoann, Voltzenlogel, Romain, Tabélé, Clémence, Chambost, Hervé, Balençon, Martine

“…Introduction In the context of severe unexplained haemorrhage (SH), it is usual to seek haematological evaluation and investigate for an inherited rare…”
Get full text

Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study by Khider, Lina, Templé, Marie, Bally, Cécile, Spaeth, Agathe, Darnige, Luc, Sanchez, Olivier, Planquette, Benjamin, Mortelette, Hélène, Messas, Emmanuel, Smadja, David M., Emmerich, Joseph, Mirault, Tristan, Kosmider, Olivier, Gendron, Nicolas

Get full text

Emicizumab and asparaginase, A first experience to share by Goubeau, Laurie, Bally, Cécile, Borgel, Delphine, Alby‐Laurent, Fanny, Petit, Arnaud, Frenzel, Laurent, Lasne, Dominique, Harroche, Annie

Get full text

The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices by Bentounes, Nûn K., Lasne, Dominique, Habay, Capucine, Bally, Cécile, Frenzel, Laurent, Harroche, Annie, Borgel, Delphine, Auditeau, Claire

Get full text

NPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents by Prata, Pedro Henrique, Bally, Cécile, Prebet, Thomas, Recher, Christian, Venton, Geoffroy, Thomas, Xavier, Raffoux, Emmanuel, Pigneux, Arnaud, Cluzeau, Thomas, Desoutter, Judith, Gay, Julie, Preudhomme, Claude, Fenaux, Pierre, Adès, Lionel

Get full text

Unique inflammatory signature in haemophilic arthropathy: miRNA changes due to interaction between blood and fibroblast‐like synoviocytes by Mignot, Sandra, Cagnard, Nicolas, Albaud, Benoit, Bally, Cécile, Siavellis, Justine, Hermine, Olivier, Frenzel, Laurent

“…In haemophilia, the recurrence of hemarthrosis leads to irreversible arthropathy termed haemophilic arthropathy (HA). However, HA is a unique form of…”
Get full text

Emicizumab does not interfere with the activated clotting time by Capdevila, Ladislas, Frère, Corinne, Desvages, Maximilien, Harroche, Annie, Bally, Cécile, Abbes, Ahmed, d'Oiron, Roseline, Frenzel, Laurent, Borgel, Delphine, Lasne, Dominique

“…Introduction The activated clotting time (ACT) is a useful marker of unfractionated heparin (UFH) activity during cardiopulmonary bypass (CPB) or cardiac…”
Get full text

Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII‐free emicizumab therapy by Capdevila, Ladislas, Borgel, Delphine, Lasne, Dominique, Lacroix‐Desmazes, Sebastien, Desvages, Maximilien, Delignat, Sandrine, Bally, Cécile, Frenzel, Laurent, Harroche, Annie

“…Introduction: The recent approval of emicizumab has significantly changed the management of severe hemophilia A. It also raises several questions, particularly…”
Get full text

Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients by Peterlin, Pierre, Cluzeau, Thomas, Jullien, Maxime, Ngo Nloga, Anne‐Marie, Calleja, Anne, Angeli, Eurydice, Chevallier, Patrice, Guillaume, Thierry, Garnier, Alice, Le Bourgeois, Amandine, Le Gouill, Steven, Fenaux, Pierre, Adès, Lionel, Bally, Cécile

Get full text

Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine by Hilmi, Marc, Bally, Cécile, Burns, Robert, Lorillon, Gwenael, Bergeron, Anne, Fenaux, Pierre, Ades, Lionel

Get full text

Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia by Renneville, Aline, Attias, Philippe, Thomas, Xavier, Bally, Cécile, Hayette, Sandrine, Farhat, Hassan, Eclache, Virginie, Marceau-Renaut, Alice, Cassinat, Bruno, Feuillard, Jean, Terré, Christine, Delabesse, Eric, Park, Sophie, Lejeune, Julie, Chevret, Sylvie, Adès, Lionel, Preudhomme, Claude, Fenaux, Pierre

Get full text

S173: RETROSPECTIVE STUDY OF LENALIDOMIDE DISCONTINUATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME HARBORING DEL(5Q). A HARMONY ALLIANCE STUDY by Crisà, Elena, Díez Campelo, María, Germing, Ulrich, Mora Castera, Elvira, Mohedo, Francisca Hernandez, Andrea, Kündgen, Freja, Ebeling, Myllymäki, Mikko, Jädersten, Martin, Lindberg, Eva Hellström, Haase, Detlef, Capodanno, Isabella, Poloni, Antonella, Finelli, Carlo, Crugnola, Monica, Fozza, Claudio, Calvisi, Anna, Frairia, Chiara, Pietrantuono, Giuseppe, Cerrano, Marco, Ciancia, Rosanna, Barraco, Daniela, Hofmann, Wolf‐Karsten, Ruefer, Axel, Bally, Cécile, Fenaux, Pierre, Sanz Santillana, Guillermo, Santini, Valeria

Get full text

Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromes by Bally, Cécile, Renneville, Aline, Preudhomme, Claude, Legrand, M, Adès, Lionel, de Thé, Hugues, Fenaux, Pierre, Lehmann-Che, Jacqueline

“…Highlights • FASAY and NGS detect TP53 mutations not identified by the other method. • FASAY can detect ins/del not well detected by NGS. • NGS can detect…”
Get full text